デフォルト表紙
市場調査レポート
商品コード
1413661

バンコマイシンの市場:タイプ、剤形、投与経路、用途、流通チャネル別-2024-2030年の世界予測

Vancomycin Market by Type (Ampicillin, Chloramphenicol, Daptomycin), Form (Capsule, Oral Solution (Liquid), Powder), Route of Administration, Application, Distribution Channel - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
バンコマイシンの市場:タイプ、剤形、投与経路、用途、流通チャネル別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バンコマイシン市場規模は2023年に6億9,323万米ドルと推定され、2024年には7億4,153万米ドルに達すると予測され、CAGR 5.26%で2030年には9億9,287万米ドルに達する見込みです。

バンコマイシンの世界市場

主な市場の統計
基準年[2023] 6億9,323万米ドル
予測年[2024] 7億4,153万米ドル
予測年 [2030] 9億9,287万米ドル
CAGR(%) 5.26%
バンコマイシン Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはバンコマイシン市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、バンコマイシン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1-市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1-バンコマイシン市場の市場規模および予測は?

2-バンコマイシン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3-バンコマイシン市場における技術動向と規制の枠組みは?

4-バンコマイシン市場における主要ベンダーの市場シェアは?

5-バンコマイシン市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で細菌感染症が蔓延
      • 感染制御に対する政府の有利な戦略
      • ジェネリック代替品のニーズの高まり
    • 抑制要因
      • バンコマイシンによる健康への悪影響
    • 機会
      • バンコマイシンの配信を最適化する革新的なアプローチ
      • バンコマイシンを適切に使用するための教育的取り組みを約束する
    • 課題
      • バンコマイシンの代替の存在
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 バンコマイシンの市場:タイプ別

  • アンピシリン
  • クロラムフェニコール
  • ダプトマイシン
  • リネゾリド
  • キヌプリスティン

第7章 バンコマイシンの市場:形態別

  • カプセル
  • 経口液(液体)

第8章 バンコマイシンの市場:投与経路別

  • 静脈内
  • オーラル

第9章 バンコマイシンの市場:用途別

  • 大腸炎と腸の炎症
  • 肺感染症
  • 敗血症
  • 皮膚軟部組織感染症

第10章 バンコマイシンの市場:流通チャネル別

  • 外来薬局
  • 病院薬局
  • オンライン薬局

第11章 南北アメリカのバンコマイシンの市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域のバンコマイシンの市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカのバンコマイシンの市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ主要企業別の分析

第15章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Alvogen
    • Aphios Corporation
    • CJ CheilJedang Corporation
    • Eli Lilly and Company
    • Enanta Pharmaceuticals, Inc.
    • GlaxoSmithKline PLC
    • Helix BioMedix, Inc.
    • Innovation Pharmaceuticals Inc.
    • LegoChem Biosciences, Inc.
    • Lytix Biopharma AS
    • MGB Biopharma
    • Microbiotix, Inc.
    • MicuRx Pharmaceuticals
    • Nabriva Therapeutics GmbH
    • North China Pharmaceutical Group Co., Ltd.
    • NovaBay Pharmaceuticals, Inc.
    • NovoBiotic Pharmaceuticals, LLC
    • Oragenics, Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Sealife Pharma GmbH
    • VIANEX
    • Xellia Pharmaceuticals ApS
    • Zealand Pharma A/S
    • Zhejiang Hisun Pharmaceutical Co., Ltd.
    • Zhejiang Pharmaceutical Co., Ltd.
  • 主要な製品ポートフォリオ

第16章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. VANCOMYCIN MARKET RESEARCH PROCESS
  • FIGURE 2. VANCOMYCIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. VANCOMYCIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. VANCOMYCIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. VANCOMYCIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. VANCOMYCIN MARKET DYNAMICS
  • FIGURE 7. VANCOMYCIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. VANCOMYCIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. VANCOMYCIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 10. VANCOMYCIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. VANCOMYCIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. VANCOMYCIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES VANCOMYCIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES VANCOMYCIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. VANCOMYCIN MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. VANCOMYCIN MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. VANCOMYCIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. VANCOMYCIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VANCOMYCIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. VANCOMYCIN MARKET SIZE, BY AMPICILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. VANCOMYCIN MARKET SIZE, BY CHLORAMPHENICOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. VANCOMYCIN MARKET SIZE, BY DAPTOMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. VANCOMYCIN MARKET SIZE, BY LINEZOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. VANCOMYCIN MARKET SIZE, BY QUINUPRISTIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 12. VANCOMYCIN MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. VANCOMYCIN MARKET SIZE, BY ORAL SOLUTION (LIQUID), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. VANCOMYCIN MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 16. VANCOMYCIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. VANCOMYCIN MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. VANCOMYCIN MARKET SIZE, BY COLITIS & INTESTINAL INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. VANCOMYCIN MARKET SIZE, BY LUNG INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. VANCOMYCIN MARKET SIZE, BY SEPSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. VANCOMYCIN MARKET SIZE, BY SKIN SOFT TISSUE INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. VANCOMYCIN MARKET SIZE, BY AMBULATORY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. VANCOMYCIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. VANCOMYCIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS VANCOMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES VANCOMYCIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. VANCOMYCIN MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 237. VANCOMYCIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. VANCOMYCIN MARKET LICENSE & PRICING
目次
Product Code: MRR-C002B1C99656

[197 Pages Report] The Vancomycin Market size was estimated at USD 693.23 million in 2023 and expected to reach USD 741.53 million in 2024, at a CAGR 5.26% to reach USD 992.87 million by 2030.

Global Vancomycin Market

KEY MARKET STATISTICS
Base Year [2023] USD 693.23 million
Estimated Year [2024] USD 741.53 million
Forecast Year [2030] USD 992.87 million
CAGR (%) 5.26%
Vancomycin Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vancomycin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vancomycin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vancomycin Market, highlighting leading vendors and their innovative profiles. These include Alvogen, Aphios Corporation, CJ CheilJedang Corporation, Eli Lilly and Company, Enanta Pharmaceuticals, Inc., GlaxoSmithKline PLC, Helix BioMedix, Inc., Innovation Pharmaceuticals Inc., LegoChem Biosciences, Inc., Lytix Biopharma AS, MGB Biopharma, Microbiotix, Inc., MicuRx Pharmaceuticals, Nabriva Therapeutics GmbH, North China Pharmaceutical Group Co., Ltd., NovaBay Pharmaceuticals, Inc., NovoBiotic Pharmaceuticals, LLC, Oragenics, Inc., Pfizer Inc., Sanofi SA, Sealife Pharma GmbH, VIANEX, Xellia Pharmaceuticals ApS, Zealand Pharma A/S, Zhejiang Hisun Pharmaceutical Co., Ltd., and Zhejiang Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Vancomycin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Ampicillin
    • Chloramphenicol
    • Daptomycin
    • Linezolid
    • Quinupristin
  • Form
    • Capsule
    • Oral Solution (Liquid)
    • Powder
  • Route of Administration
    • Intravenous
    • Oral
  • Application
    • Colitis & Intestinal Inflammation
    • Lung Infection
    • Sepsis
    • Skin Soft Tissue Infection
  • Distribution Channel
    • Ambulatory Pharmacy
    • Hospital Pharmacy
    • Online Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Vancomycin Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vancomycin Market?

3. What are the technology trends and regulatory frameworks in the Vancomycin Market?

4. What is the market share of the leading vendors in the Vancomycin Market?

5. Which modes and strategic moves are suitable for entering the Vancomycin Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Vancomycin Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of bacterial infections across the globe
      • 5.1.1.2. Favorable government strategies for infection control
      • 5.1.1.3. Rising need for generic alternatives
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impacts of vancomycin
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative approaches to optimize the delivery of vancomycin
      • 5.1.3.2. Promising educational initiatives for adequate vancomycin use
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative substitutes of vancomycin
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Vancomycin Market, by Type

  • 6.1. Introduction
  • 6.2. Ampicillin
  • 6.3. Chloramphenicol
  • 6.4. Daptomycin
  • 6.5. Linezolid
  • 6.6. Quinupristin

7. Vancomycin Market, by Form

  • 7.1. Introduction
  • 7.2. Capsule
  • 7.3. Oral Solution (Liquid)
  • 7.4. Powder

8. Vancomycin Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Intravenous
  • 8.3. Oral

9. Vancomycin Market, by Application

  • 9.1. Introduction
  • 9.2. Colitis & Intestinal Inflammation
  • 9.3. Lung Infection
  • 9.4. Sepsis
  • 9.5. Skin Soft Tissue Infection

10. Vancomycin Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Ambulatory Pharmacy
  • 10.3. Hospital Pharmacy
  • 10.4. Online Pharmacy

11. Americas Vancomycin Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Vancomycin Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Vancomycin Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Alvogen
    • 15.1.2. Aphios Corporation
    • 15.1.3. CJ CheilJedang Corporation
    • 15.1.4. Eli Lilly and Company
    • 15.1.5. Enanta Pharmaceuticals, Inc.
    • 15.1.6. GlaxoSmithKline PLC
    • 15.1.7. Helix BioMedix, Inc.
    • 15.1.8. Innovation Pharmaceuticals Inc.
    • 15.1.9. LegoChem Biosciences, Inc.
    • 15.1.10. Lytix Biopharma AS
    • 15.1.11. MGB Biopharma
    • 15.1.12. Microbiotix, Inc.
    • 15.1.13. MicuRx Pharmaceuticals
    • 15.1.14. Nabriva Therapeutics GmbH
    • 15.1.15. North China Pharmaceutical Group Co., Ltd.
    • 15.1.16. NovaBay Pharmaceuticals, Inc.
    • 15.1.17. NovoBiotic Pharmaceuticals, LLC
    • 15.1.18. Oragenics, Inc.
    • 15.1.19. Pfizer Inc.
    • 15.1.20. Sanofi SA
    • 15.1.21. Sealife Pharma GmbH
    • 15.1.22. VIANEX
    • 15.1.23. Xellia Pharmaceuticals ApS
    • 15.1.24. Zealand Pharma A/S
    • 15.1.25. Zhejiang Hisun Pharmaceutical Co., Ltd.
    • 15.1.26. Zhejiang Pharmaceutical Co., Ltd.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing